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Kenna et al., 1994). From a clinical point of view, the
Familial arrhythmogenic right ventricular cardio- onset of ARVD is usually characterized by ventricular
myopathy or dysplasia (ARVD) is an idiopathic heart arrhythmias of right ventricular origin and sometimes
muscle disease with an autosomal-dominant pattern by symptoms of right heart failure (Pinamonti et al.,
of transmission, characterized by ®bro-fatty replace- 1992). Depolarization and repolarization changes, such
ment of the right ventricular myocardium and ventric- as inverted T waves in right precordial leads, epsilon
ular arrhythmias. Recently, linkage to the chromo- waves, and late potentials on signal-averaged electro-
some 14q23±q24 (locus D14S42) has been reported in cardiograms, are frequently found. Structural and
two families. In the present study, three unrelated functional alterations of the right ventricle can be de-
families with ARVD were investigated. According to tected by echocardiography, angiography, magnetic
strict diagnostic criteria, 13 of 37 members were con- resonance imaging, or radionuclide scintigraphy. Thesesidered to be affected. Linkage to the D14S42 locus was alterations can be localized (dyskinetic bulges, segmen-excluded. On the other hand, linkage was found in the
tal dilatation, or hypokinesia) or diffuse. The gold stan-region 14q12±q22 in all three families (cumulative two-
dard for diagnosis of ARVD is the histological demon-point lod score is 3.26 for D14S252), with no recombina-
stration of a fatty or ®bro-fatty substitution of the righttion between the detected locus and the disease gene.
ventricular myocardium (McKenna et al., 1994).With multipoint linkage analysis, a maximal cumula-
At present, the incidence of the disease is unknowntive lod score of 4.7 was obtained in the region between
and is probably underestimated. The etiology is alsoloci D14S252 and D14S257. These data indicate that a
unknown. However, in about 30% of cases, a familialnovel gene causing familial ARVD (provisionally
occurrence with autosomal-dominant inheritance hasnamed ARVD2) maps to the long arm of chromosome
been reported (McKenna et al., 1994; Nava et al., 1988;14, thus supporting the hypothesis of genetic heteroge-
neity in this disease. q 1996 Academic Press, Inc. Miani et al., 1993). Clinical studies have shown a re-
duced penetrance (Nava et al., 1990) and a delayed age
of onset (Thiene et al., 1990; Camerini et al., 1994)
INTRODUCTION in familial ARVD. The variability of penetrance and
clinical expression indicates genetic heterogeneity
Arrhythmogenic right ventricular dysplasia (ARVD) (Nava et al., 1990), suggesting that different genes are
is an idiopathic heart muscle disorder, anatomically likely to be responsible for the disease phenotype.
characterized by fatty or ®bro-fatty in®ltration of the Recently, in a large four-generation kindred and in
right ventricular myocardium (Thiene et al., 1988; Mc- another small family, the disease was found to be
linked to the polymorphic marker D14S42, which maps
to region 14q23±q24 (Rampazzo et al., 1994). To test1 To whom correspondence should be addressed at ICGEB, AREA
Science Park, Padriciano 99, 34012 Trieste, Italy. Telephone: /39- the hypothesis of genetic heterogeneity, we performed
40-3757326. Fax: /39-40-226555. linkage analysis in three unrelated kindreds with fa-
2 Heart Muscle Disease Study Group: Andrea Di Lenarda, M.D., milial ARVD.Gerardina Lardieri, M.D., Tullio Morgera, M.D., Furio Silvestri,
M.D., Rossana Bussani, M.D., and Milla Davanzo, R.N. (Depart-
ments of Cardiology and of Morbid Anatomy, Ospedale Maggiore and MATERIALS AND METHODS
University, Trieste, Italy); Matteo Vatta, M.Sc., and Jelena Milasin,
Ph.D. (Molecular Cardiology, International Centre for Genetic Engi- Clinical evaluation. Three unrelated families of different ethnic
origins (Italy, Slovenia, and Belgium) underwent clinical and geneticneering and Biotechnology, AREA Science Park, Trieste, Italy).
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FIG. 1. Pedigrees with haplotype data of the three analyzed families. Males are represented by squares, females by circles, and dead
family members by symbols with diagonals. The symbols are shaded black for individuals with de®ned ARVD and gray for individuals of
uncertain clinical diagnosis. Individuals with a question mark inside the symbol were not included in this study. Markers cosegregating
with the disorder are boxed. Haplotypes of individuals III-5 and III-6 of family A (dashed line) were inferred. Recombination events in the
disease-associated chromosome are indicated by an X between the recombinant markers. Paternity analysis excluded individuals III-1, IV-
1, IV-6, and V-4 of family A from the linkage study. The proband in each family is identi®ed by an arrow.
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TABLE 1
Clinical Features of the Affected Members with Familial ARVD
ESC/ISFC
criteriae
Clinical Final
Agea Sex ®ndings ECGb VENTR. ARRH. SAECGc RV ABNd RV pathology Major Minor diagnosis
Family A
III-2 49 M Syncope, AF,g LAHh VTi (LBBB j LPk Severe HYPOl / DILm / Bn Fibro-fatty 3 2 ARVD
RHL, LHFf type) in®ltration (EMBo)
III-3 51 F RHF AF, 37AVB,p T- VT (LBBB type) Severe HYPO / DIL / B Fibro-fatty 3 3 ARVD
in RPL,q in®ltration
EWr (autopsy)
VI-7 49 M Asymptomatic EW VEBs LP HYPO / DIL / B 3 1 ARVD
IV-9 36 F Syncope, AF, 17-37AVB VT (LBBB type) Diffuse HYPO / DIL / B Fatty in®ltration 3 1 ARVD
LHF, RHF (EMB)
IV-10 29 M Syncope SSS,t 17AVB, VT (LBBB type) LP Diffuse HYPO / DIL / B Hypertrophy, endoc. 3 2 ARVD
EW ®brosis (EMB)
V-5 19 F Asymptomatic T-in RPL VEB, VT (LBBB Normal Mild HYPO / DIL 1 4 ARVD
type)
Family B
I-2 80 M Asymptomatic Prolonged QRS DIL / HYPO / B 2 1 ARVD
(V1-V3)
II-2 20 F Syncope Normal VT (LBBB type) LP DIL / HYPO / B Mild hypertrophy 1 3 ARVD
(EMB)
III-3 12 M Asymptomatic Normal VEB Normal DIL / HYPO / B 1 2 ARVD
Family C
II-7 63 M Syncope AF, AT,u LAH VT (LBBB type) HYPO / DIL / B / FAT v 1 2 ARVD
III-1 33 F Syncope, T-in RPL VT (LBBB type) LP Diffuse HYPO / DIL / B 1 4 ARVD
aborted SDw / FAT
III-2 17 F Asymptomatic T-in RPL Normal HYPO / B 1 2 ARVD
III-5 29 M Palpitations Normal Not documented LP Normal 0 2 Unknown
aAge at ®rst symptom; bECG, electrocardiogram; cSAECG, signal-averaged ECG; dRV ABN, right ventricular abnormalities (echocardiogra-
phy, angiography, magnetic resonance imaging); eaccording to McKenna et al., 1994; f RHF, right heart failure; LHF, left heart failure; gAF,
atrial ®brillation; hLAH, left anterior hemiblock; iVT, ventricular tachycardia; jLBBB, left bundle branch block; kLP, late potentials; lHYPO,
hypokinesis; mDIL, dilatation; nB, bulge; oEMB, endomyocardial biopsy; pAVB, atrioventricular block; qT-in RPL, inverted T wave in right
precordial leads; r EW, epsilon waves; sVEB, ventricular ectopic beats; tSSS, sick sinus syndrome; uAT, atrial tachycardia; vFAT, fatty
in®latration; wSD, sudden death.
studies beginning in 1991 (Fig. 1). The three kindred were selected Polymorphic microsatellite sequences (CA repeats) with high per-
from a group of six families with ARVD because of their suf®cient centages of heterozygosity (Jordan et al., 1990; Wang and Weber,
informativity, without any other preselection criteria. Thirty-seven 1992; Weissenbach et al., 1992; Gyapay et al., 1994) were ampli®ed
members were clinically evaluated with electrocardiography using using the polymerase chain reaction (PCR) technique.
supplementary chest leads (V4R, V3R, V7, and V8) and with M- PCR ampli®cations were carried out in 50 ml of a solution con-
mode, 2D, and Doppler echocardiography (Pinamonti et al., 1992). taining Tris±HCl, 10 mM (pH 8.0); KCl, 50 mM; MgCl2, 1.5 mM;
The evaluation was completed by signal-averaged electrocardiogra- gelatin 0.01%; each dNTP, 200 mM; each primer, 0.1 mM; 200 ng of
phy according to current recommendations (Breithardt et al., 1991) template DNA; and 2.5 units of Taq DNA polymerase (Perkin Elmer,
in 16 subjects, by magnetic resonance in 9, by left and/or right ven- Roche Molecular Systems, Branchburg, NJ), with 40 repetitions of
tricular angiography in 8, and by right endomyocardial biopsy in 5. the following cycle: 30 s at 947C, 30 s at the annealing temperature,
Postmortem examination was performed in 1 case. For the de®nition and 30 s at 727C in the Eppendorf Master Cycler 5330. Annealing
of the diagnosis and of the clinical status, the criteria proposed by temperatures varied from 52 to 627C, according to the different
the ARVD ESC/ISFC task force (McKenna et al., 1994) were strictly primer pairs. PCR products were resolved by a long run on a 10 ±
applied. In summary, the diagnosis was based on the analysis of six 12% polyacrylamide native gel and visualized by ethidium bromide
main groups of diagnostic criteria: (1) global and/or regional dysfunc- staining. All the oligonucleotides were synthesized by the ICGEB
tion and structural alterations; (2) tissue characterization of walls; oligonucleotide synthesis service on an Applied Biosystems 380B
(3) repolarization abnormalities; (4) depolarization/conduction ab- synthesizer.
normalities; (5) arrhythmias; and (6) familial history. In each group,
Linkage analysis. All polymorphisms were scored without knowl-major and minor criteria were considered: the diagnosis of ARVD
edge of phenotypic data and by two independent observers. Two-depended on the presence of two major criteria from different diag-
point and multipoint lod scores were calculated using the LINKAGEnostic groups, of one major plus two minor criteria, or of four minor
software package Version 5.2 (Lathrop et al., 1984; Lathrop and La-criteria. The clinical status of the affected and unaffected relatives
louel, 1985) on a SUN SPARC Server 10-401 computer. For the calcu-was examined periodically during the follow-up. The phenotypic data
lation, the existence of an autosomal-dominant ARVD gene with awere interpreted without knowledge of genotype. The age of the unaf-
gene frequency of 0.0001, an equal female and male recombinationfected key members was over 20 years.
rate, and equal marker allele frequencies were assumed. In allGenetic analysis. DNA samples from all available family mem-
events, the results were not signi®cantly affected by modi®cationsbers were extracted according to the salting out procedure (Miller et
of allele frequency calculated from families (Boehnke, 1991) at theseal., 1988), either from fresh blood samples or from continuous B-
loci. Family members under 18 years, with the exception of thoselymphocyte cell lines immortalized with the Epstein±Barr virus
found to be affected (family B, III-3, and family C, III-5; Table 1 and(Neitzel 1986). In the case of one deceased patient (family A III-3,
Fig. 1), were excluded from the study, to avoid the low penetranceFig. 1), DNA was extracted from a paraf®n-embedded tissue sample
(Jackson et al., 1991). in this age group (10%, based on our clinical observations). For the
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FIG. 2. Histological section of the right ventricular free wall from patient III-3 (family A). The muscle component is replaced by fatty
tissue and by a thin layer of subendocardial connective tissue. Residual myocardial cells are present within the trabeculae (Azan; original
magni®cation 12.5).
lod score calculations, the penetrance was assumed to be 100%; how- rized in Table 1. The mean age at the ®rst symptom
ever, to test the stability of the obtained lod values, the maximum was 37, ranging from 12 to 80 (family B, I-2 and III-
two-point lod scores were recalculated, varying the penetrance from 3, respectively), thus demonstrating the variability of100 to 90%. The calculations of the two-point lod scores were per-
expression. No signi®cant sex difference was detected.formed at recombination fractions of 0, 0.01, 0.05, 0.1, 0.2, 0.3, and
0.4 between each marker and the putative disease gene. The SIM- The majority of patients suffered from symptoms re-
LINK computer program (Ploughman et al., 1989) and the HOMOG lated to complex ventricular arrhythmias at presenta-
program (Ott, 1991) were used, respectively, to verify the appropriate tion. Patient III-3 of family A had isolated right heart
linkage power and to test the homogeneity of the series of families
failure. Five cases were asymptomatic and were de-analyzed.
tected incidentally during the familial screening. The
left ventricular cavity was not signi®cantly enlarged in
RESULTS any patient. However, cases III-2 and IV-9 of family A
developed signs of left ventricular involvement, with
Clinical Analysis reduced ejection fraction (43 and 51%, respectively).
Transmural ®bro-fatty replacement of the right ven-Three unrelated families of different ethnic origins
tricular myocardium was demonstrated at autopsy inwith familial transmission of ARVD were analyzed in
patient III-3 of family A (Fig. 2). The presence of rele-this study.
vant ®bro-fatty substitution was found at endomyocar-According to the criteria of the ESC/ISFC task force
dial biopsy in patients III-2 and IV-9 of family A. His-for the diagnosis of ARVD (McKenna et al., 1994), 13
tology showed aspeci®c changes in two other casesfamily members were considered to be affected; of
(family A, IV-10, and family B, II-2). Fatty in®ltrationthese, 1 young subject (family A, V-5) developed signs
was identi®ed by nuclear magnetic resonance imagingof ARVD during the follow-up. The clinical status of
in two affected family C members (II-7 and III-1).another individual (family C, III-5), showing minor ab-
normalities that were not suf®cient for a de®nitive di-
Linkage Analysis for the ARVD1 Locus (14q23±q24)agnosis, was considered as unknown for the purpose of
genetic analysis. In all families, ARVD was inherited Linkage analysis was performed on 33 members of
the three families: 14 from family A, 11 from familyas an autosomal-dominant trait with age-related pene-
trance (Fig. 1). B, and 8 from family C (Fig. 1). Four subjects from
family A (III-1, IV-1, IV-6, and V-4) were excludedThe clinical features of the 13 patients are summa-
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TABLE 2 recombinants were found in family A (IV-2), in family
B (III-1 and II-3), and in family C (II-5 and III-6).Cumulative and Pedigree-Speci®c Lod Scores Ob-
tained at Different Values of Recombination Fraction
Linkage of ARVD to 14q12±q22(u) with Two-Point Linkage Analysis for Loci D14S71
(Gyapay et al., 1994), D14S42 (Jordan et al., 1990),
Ten microsatellite markers with a heterozygosity in-D14S76, D14S61, and D14S74 (Gyapay et al., 1994)
dex greater than 0.75 and located every 10 ±15 cM were
u used to analyze chromosome 14. Linkage to locus
MYH7 (14q11± q12), corresponding to the localization
Loci 0.00 0.01 0.02 0.03 0.04 0.05 of the cardiac b myosin heavy chain gene, was ex-
cluded. Since a positive result was obtained for locusD14S71 Cumulative 0Inf.a 03.97 02.81 02.17 01.72 01.37
D14S70, genotyping was performed with six additionalFamily A 02.24 00.06 0.21 0.35 0.44 0.51
Family B 0Inf. 01.11 00.81 00.65 00.53 00.44 markers (Gyapay et al., 1994) in this region (Fig. 1).
Family C 0Inf. 02.80 02.21 01.87 01.63 01.44 With two-point linkage analysis, positive lod scores
were obtained for three microsatellite markers (TableD14S42 Cumulative 0Inf. 00.99 00.70 00.54 00.43 00.34
Family A 0.12 0.12 0.11 0.11 0.10 0.10 3): AFM207xb12 (locus D14S252), AFM224yb8
Family B 0Inf. 01.11 00.81 00.65 00.53 00.44 (D14S257), and AFM191ve1 (D14S70), mapping ap-
Family C 0.00 0.00 0.00 0.00 0.00 0.00 proximately to chromosome 14q12±q22 and spanning
D14S76 Cumulative 02.62 00.47 00.20 00.05 0.05 0.11 a region of 11 cM. Signi®cant cumulative lod scores
Family A 02.62 00.47 00.20 00.05 0.05 0.11 (3.26 for D14S252 and 3.07 for D14S70) were detected
Family B 0.00 0.00 0.00 0.00 0.00 0.00 at a recombination fraction of 0, indicating completeFamily C 0.00 0.00 0.00 0.00 0.00 0.00
linkage. Lod score values also remained signi®cantly
D14S61 Cumulative 0Inf. 07.05 05.30 04.30 03.61 03.08 positive (⁄3) after reducing penetrance to 85%, as well
Family A 07.17 02.33 01.75 01.41 01.18 01.01 as after changing allele marker frequencies. ChangesFamily B 0Inf. 01.92 01.34 01.02 00.80 00.63
in the affection status when performing the sensitivityFamily C 0Inf. 02.80 02.21 01.87 01.63 01.44
test (Hodge and Greenberg, 1992) did not affect the lod
D14S74 Cumulative 0Inf. 00.62 00.33 00.16 00.05 0.03 values.Family A 0.18 0.19 0.20 0.21 0.21 0.22
In accordance with the results of two-point linkageFamily B 0Inf. 00.81 00.53 00.37 00.26 00.19
analysis, haplotype analysis detected an obligate re-Family C 0.00 0.00 0.00 0.00 0.00 0.00
combination event between the disease gene and locus
a Minus in®nity. D14S69 for individual IV-9 of family A. Another obli-
gate recombination event occurred between ARVD and
locus D14S262, as shown by the different alleles infrom the linkage study according to the results of a
individuals III-2 and III-3 compared to that in the otherpaternity test.
affected relatives (IV-7, VI-8, and IV-10), thus settingFamily members were ®rst examined with a group of
the boundaries for the disease gene locus. No recombi-®ve microsatellite markers spread in a region of about 5
nation event was observed within this region.cM (Gyapay et al., 1994; Murray et al., 1994; Cox Ma-
To determine the most likely location for the diseasetise et al., 1994) corresponding to the region of the locus
locus, multipoint linkage analysis was performed usingD14S42 (Jordan et al., 1990), the ®rst identi®ed ARVD
®ve adjacent loci. Multipoint linkage analysis con-locus (ARVD1) (Rampazzo et al., 1994). The results of
®rmed the ®ndings of two-point and haplotype analysestwo-point linkage analysis are shown in Table 2, where
by placing the disease gene between loci D14S252 andthe locus order is based on the GeÂneÂthon map (Gyapay
D14S70, with a maximum multipoint lod score of 4.7et al., 1994). Two-point linkage analysis led to the ex-
(Fig. 3). These data suggest that the novel gene forclusion of linkage with the ARVD1 locus in our families
ARVD is located between the loci D14S262 andwith marker D14S61. D14S42 (PIC 0.65) (Jordan et
D14S69, in a 15-cM region of chromosome 14, at a dis-al., 1990) was not informative. Results did not change
tance of about 30 cM from the previously reportedsigni®cantly by varying the penetrance from 90 to
ARVD gene (Rampazzo et al., 1994) (Fig. 4).100%. Multipoint linkage analysis (data not shown)
con®rmed the absence of linkage with the ARVD1 re-
gion. HOMOG analysis rejected the hypotheses of link- DISCUSSION
age and of heterogeneity.
The de®nitive evidence against linkage with the Recently, a linkage study performed in two families
D14S42 locus derived from the haplotype analysis, with ARVD suggested that the disease gene maps to
demonstrating several recombinants in the three region q23 ±q24 of chromosome 14 and is closely associ-
ARVD families. A critical recombination occurred in ated to the marker D14S42 (Rampazzo et al., 1994). In
the ®rst generations of family A, in which affected this report, we present the evidence of a novel locus,
members II-2 and II-3 were shown to carry a different ARVD2, localized to the long arm of chromosome 14 in
region q12 ±q22.allele than that in the other affected relatives. Other
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TABLE 3
Cumulative and Pedigree-Speci®c Lod Scores Obtained at Different Values of Recombination Fraction (u)
with the Two-Point Linkage Analysis for the Loci D14S262, D14S252, D14S257, D14S70, and D14S69 (Gyapay et
al., 1994)
u
Loci 0.00 0.01 0.05 0.10 0.20 0.30 0.40
D14S80 Cumulative 0Inf. 01.32 0.47 0.98 1.02 0.65 0.29
Family A 02.73 00.58 0.01 0.17 0.17 0.05 00.05
Family B 0Inf. 01.92 00.63 00.17 0.13 0.16 0.09
Family C 1.20 1.18 1.09 0.98 0.72 0.44 0.15
D14S262 Cumulative 01.27 00.93 1.40 1.43 1.14 0.71 0.20
Family A 03.37 01.14 00.50 00.27 00.10 00.03 00.01
Family B 1.20 1.18 1.09 0.98 0.72 0.44 0.15
Family C 0.90 0.89 0.81 0.72 0.52 0.30 0.09
D14S252 Cumulative 3.26 3.20 2.96 2.64 1.96 1.23 0.50
Family A 1.16 1.13 1.03 0.90 0.63 0.36 0.12
Family B 0.90 0.89 0.84 0.77 0.61 0.44 0.24
Family C 1.20 1.18 1.09 0.98 0.72 0.44 0.15
D14S257 Cumulative 0.38 0.37 0.32 0.26 0.15 0.07 0.02
Family A 0.38 0.37 0.32 0.26 0.15 0.07 0.02
Family B 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Family C 0.00 0.00 0.00 0.00 0.00 0.00 0.00
D14S70 Cumulative 3.07 3.02 2.78 2.48 1.83 1.18 0.52
Family A 0.97 0.95 0.85 0.73 0.50 0.30 0.13
Family B 0.90 0.89 0.84 0.77 0.61 0.44 0.24
Family C 1.20 1.18 1.09 0.98 0.72 0.44 0.15
D14S69 Cumulative 0Inf. 00.92 0.28 0.63 0.71 0.51 0.21
Family A 0Inf. 02.40 01.09 00.60 00.21 00.07 00.02
Family B 1.51 1.48 1.37 1.23 0.92 0.58 0.23
Family C 0.00 0.00 0.00 0.00 0.00 0.00 0.00
D14S278 Cumulative 0Inf. 03.15 01.20 00.49 0.02 0.17 0.14
Family A 0Inf. 01.23 00.59 00.37 00.20 00.12 00.06
Family B 0Inf. 01.91 00.61 00.12 0.22 0.29 0.20
Family C 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Using stringent clinical and genetic criteria, we stud- A founder effect, with a high concentration of cases
in a limited geographic area, was hypothesized in theied three families of various descent (Italian, Slo-
venian, and Belgian) with ARVD. The clinical assess- case of the ARVD1 gene (Rampazzo et al., 1994). How-
ever, our data, showing a homogeneous linkage in fami-ment was based on the criteria recently stated by the
ARVD ESC/ISFC task force (McKenna et al., 1994). All lies with different ethnic origins, suggest that the
ARVD2 gene can account for the disease in variousfamilies had an autosomal-dominant pattern of trans-
mission. populations.
The possibility of genetic heterogeneity is not sur-The results obtained from the genetic study clearly
indicate that the previously identi®ed ARVD1 locus is prising in familial ARVD and was previously hypothe-
sized in clinical studies, according to the large variabil-not linked to the disease in these families. In fact,
marker D14S42 (which has been linked to the disease) ity of phenotypic expression (McKenna et al., 1994;
Nava et al., 1990). Likewise, genetic heterogeneity hasas well as other markers in the same region (corre-
sponding to loci D14S71, D14S76, D14S61, and been found by molecular genetic studies in other myo-
cardial disorders. In familial hypertrophic cardiomyop-D14S74) yield clearly negative lod scores (incidentally,
the latter group of markers was also negative even in athy, mutations in chromosomes 1q3 (cardiac troponin
T gene) (Watkins et al., 1993; Thierfelder et al., 1994),the study of Rampazzo et al., 1994).
By screening the whole of chromosome 14, a novel 11p13±q13 (Carrier et al., 1993), and 15q2 (a-tropomy-
osin gene) (Thierfelder et al., 1993, 1994) have beenlocalization for the disease gene was detected between
loci D14S262 and D14S69 (maximum combined lod identi®ed, in addition to more than 15 different muta-
tions in the cardiac bmyosin heavy chain gene on chro-score is 4.7), without any apparent recombination event
in all these families. This new locus (ARVD2) is located mosome 14. In addition, the genes responsible for an-
other arrhythmic syndrome, the long QT syndrome,approximately 30 cM centromeric to ARVD1.
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have been mapped to chromosome 11 (Keating, 1992)
and very recently also to chromosomes 3 and 7 (Jiang
et al., 1994).
Since not all the markers located in the chromosome
14 candidate region have been physically mapped so
far (Murray et al., 1994), the location of the ARVD2
gene is still approximate. However, the exclusion of
linkage to loci MYH7 (14q11±q12) and D14S42
(14q23±q24) and the genetic mapping of D14S69 and
D14S262 (Gyapay et al., 1994) enable us to locate the
ARVD2 gene to 14q12±q22 (Fig. 4). This region of chro-
mosome 14 is relatively poor in identi®ed genes, and
none of them seems to be an obvious candidate gene
(Murray et al., 1994; Billingsley et al., 1994). Among
them, the glycogen phosphorylase gene is related to the
glycogen storage disease type VI, leading to a storage
heart disease quite different from ARVD. b-Spectrin
and a-actinin, other possible candidate genes, were
mapped to different regions (14q22±q24). It is expected
that the extension of the analysis to other families and
the development of new markers ¯anking the ARVD2
locus will facilitate a positional cloning strategy to
FIG. 4. Physical and genetic maps (left and right, respectively)identify the gene and eventually to detect the muta-
of the chromosome 14q region containing the ARVD2 locus. In thetions causing the disease.
genetic map, the sex-average recombination fractions are shown be-Among young people, ARVD represents one of the tween adjacent markers. The ARVD2 locus lies between markers
®rst causes of sudden and unexpected death, which can D14S262 and D14S69, physically located in the region 14q12±14q22.
Distances are given in centimorgans, based on the GeÂneÂthon 1994even be the presenting event (Thiene et al., 1988). Due
data (Gyapay et al., 1994).to the age-related penetrance of the disease, in particu-
lar the gene-carriers of young age can appear com-
pletely normal at clinical examinations, while being at based on the understanding of the molecular mecha-
risk of life-threatening arrhythmias. During the follow- nisms that control the cardiac structure and function.
up, we observed the development of ARVD in a 19-
year-old patient, previously examined and considered
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possible the development of new therapeutic strategies,
Note added in proof. A further ARVD locus on Chromosome 1q42±
q43 has recently been described by other authors (Rampazzo et al.,
1995).
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